Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2159425rdf:typepubmed:Citationlld:pubmed
pubmed-article:2159425lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:2159425lifeskim:mentionsumls-concept:C0032105lld:lifeskim
pubmed-article:2159425lifeskim:mentionsumls-concept:C0023516lld:lifeskim
pubmed-article:2159425lifeskim:mentionsumls-concept:C0002191lld:lifeskim
pubmed-article:2159425lifeskim:mentionsumls-concept:C0162745lld:lifeskim
pubmed-article:2159425lifeskim:mentionsumls-concept:C2612881lld:lifeskim
pubmed-article:2159425pubmed:issue2lld:pubmed
pubmed-article:2159425pubmed:dateCreated1990-6-11lld:pubmed
pubmed-article:2159425pubmed:abstractTextHighly purified human polymorphonuclear leucocyte collagenase cleaved human alpha-1-proteinase inhibitor (alpha 1-PI) at the carboxyl site of Phe352 (P7). The inhibitor was thereby rapidly inactivated and generated a primary degradation product as shown by reverse-phase HPLC and N-terminal sequencing. Prolonged incubation of the modified inhibitor with polymorphonuclear leucocyte collagenase led to the generation of a secondary degradation product with additional cleavage at the carboxyl site of Pro357 (P2).lld:pubmed
pubmed-article:2159425pubmed:languageenglld:pubmed
pubmed-article:2159425pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2159425pubmed:citationSubsetIMlld:pubmed
pubmed-article:2159425pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2159425pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2159425pubmed:statusMEDLINElld:pubmed
pubmed-article:2159425pubmed:monthAprlld:pubmed
pubmed-article:2159425pubmed:issn0014-5793lld:pubmed
pubmed-article:2159425pubmed:authorpubmed-author:TschescheHHlld:pubmed
pubmed-article:2159425pubmed:authorpubmed-author:ReinkeHHlld:pubmed
pubmed-article:2159425pubmed:authorpubmed-author:KnäuperVVlld:pubmed
pubmed-article:2159425pubmed:issnTypePrintlld:pubmed
pubmed-article:2159425pubmed:day24lld:pubmed
pubmed-article:2159425pubmed:volume263lld:pubmed
pubmed-article:2159425pubmed:ownerNLMlld:pubmed
pubmed-article:2159425pubmed:authorsCompleteYlld:pubmed
pubmed-article:2159425pubmed:pagination355-7lld:pubmed
pubmed-article:2159425pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2159425pubmed:meshHeadingpubmed-meshheading:2159425-...lld:pubmed
pubmed-article:2159425pubmed:meshHeadingpubmed-meshheading:2159425-...lld:pubmed
pubmed-article:2159425pubmed:meshHeadingpubmed-meshheading:2159425-...lld:pubmed
pubmed-article:2159425pubmed:meshHeadingpubmed-meshheading:2159425-...lld:pubmed
pubmed-article:2159425pubmed:meshHeadingpubmed-meshheading:2159425-...lld:pubmed
pubmed-article:2159425pubmed:meshHeadingpubmed-meshheading:2159425-...lld:pubmed
pubmed-article:2159425pubmed:meshHeadingpubmed-meshheading:2159425-...lld:pubmed
pubmed-article:2159425pubmed:year1990lld:pubmed
pubmed-article:2159425pubmed:articleTitleInactivation of human plasma alpha 1-proteinase inhibitor by human PMN leucocyte collagenase.lld:pubmed
pubmed-article:2159425pubmed:affiliationUniversity of Bielefeld, Faculty of Chemistry, Department of Biochemistry, FRG.lld:pubmed
pubmed-article:2159425pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2159425pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2159425lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2159425lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2159425lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2159425lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2159425lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2159425lld:pubmed